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Introduction 
Hearing loss (HL) is the most common sensory 
deficit in humans with an incidence of about one 
in 650 newborns. The prevalence continues to in-
crease during childhood and reaches a rate of 2.7 
per 1000 children before the age of five years and 
3.5 per 1000 during adolescence. HL is a major 
public health concern in developing countries. Two 
thirds of the people who have HL worldwide live 
in developing countries (1). A severe HL in early 
childhood prevents from proper speech acquisition 
and subsequent literacy and its later onset would 
negatively affect the quality of life (2). As sani-
tary indexes are improved, the figure would change 
in favor of the role of genetics (3, 4).  HL can be 
classified by different criteria including severity 
(mild: 20 to 39 dB, moderate: 40 to 69 dB, severe: 
70 to 89 dB, or profound: ≥90 dB), age of onset 
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(pre-lingual or post-lingual), origin (conductive, sen-
sorineural or mixed) and presence or absence of as-
sociated features (syndromic or non-syndromic) (5). 
 It is estimated that at least 50% of pre-lingual 
HL has a genetic basis. The etiology for another 
25% remains unclear, suggesting an additional role 
for genetics. Approximately 70% of genetic HL 
cases are non-syndromic (NSHL), where no other 
anomaly exists, whereas the remaining 30% are 
syndromic. Up to now, over 400 syndromic forms 
have been described; Usher syndrome and Pen-
dred syndrome are the most common examples (6). 
Whilst in NSHL, autosomal-dominant (ADNSHL) 
comprises ~20% and only a minority of the causes 
include X-linked (~1%) and mitochondrial (<1%) 
forms, Autosomal-recessive forms (ARNSHL) en-
compasses ~ 80% of cases (3, 4). Notably, the 
frequency of ARNSHL becomes even higher in 
countries with high rate of consanguineous mar-
riage (3). ARNSHL forms are usually pre-lingual 
and more severe in degree and are almost exclu-
sively sensorineural (4, 7). The loci for ARNSHL, 
ADNSHL and X-linked HL are represented by 
DFNB, DFNA and DFN, respectively (4). Up to 
1% of human genes are estimated to be involved 
in hearing process. Over 130 loci have been identi-
fied for NSHL so far. Thus, HL is one of the most 
heterogeneous human genetic trait (6, 8), of which 
more than 70 DFNB loci have been identified for 
ARNSHL (9). 
Iran, with the average consanguineous marriage 
rate of 38.6% (10) and with a heterogeneous po-
pulation due to different ethnicities, can provide a 
good opportunity for genetic research on ARNSHL. 
However, further research has been highly rec-
ommended to obtain an insight into the contributing 
loci, some of which might be new (11). Most 
studies in Iran on ARNSHL have only addressed 
certain loci with a special focus on DFNB1 (GJB2), 
the most common cause of ARNSHL. Studying 
other loci in the Iranian ARNSHL patients would 
provide insight into the role of other loci in patho-
genesis of ARNSHL in this population. The results 
of such studies could be applied to a more effi-
cient genetic screening of the disease and the con-
comitant DNA diagnostics and genetic counseling.  
The present study was launched to determine the 
contribution of DFNB1 (GJB2, GJB6) and 14 other 
DFNB loci to ARNSHL in the study cohort.  
 
Materials and Methods 
 
Subjects and clinical evaluation 
This study was approved by the Institutional Re-
view Boards of Shahrekord University of Medical 
Sciences and the University of Antwerp in Bel-
gium. In this descriptive study, a number of families 
with Iranian origin were collected from 7 prov-
inces of Iran, including Charmahal va Bakhtiari, 
Fars, Guilan, Tehran, Khuzestan, Azerbaijan Sharghi 
and Kurdestan.  
HL informational questionnaires were filled out for 
all families and the pedigrees were drawn based 
on the filled-out questionnaires and interview with 
the members of the families. Families with the pos-
sibility of exposure to known environmental risk 
factors (head trauma, the use of ototoxic drugs, 
etc.) were excluded from the study. In total, 37 
families with at least 4 patients were included in 
this study. All, but one family with Pendred syn-
drome, were affected with ARNSHL. Participants 
signed an informed consent form before their in-
clusion into this study. Pure tone audiometric test 
for air and bone conduction at frequencies varying 
from 250 to 8000 Hz was performed. 
 
DNA extraction 
DNA was extracted from EDTA-containing blood 
samples of participating individuals using the phenol/ 
chloroform standard procedure (12). DNA quali-
ties were checked on 1.2% agarose gel. A Nano-
Drop 1000 spectrophotometer (Thermo Scientific 
Inc., Wilmington, DE, USA) was used to deter-
mine DNA concentration and purity. 
 
GJB2 mutation screening  
At least, one patient from every pedigree was sub-
jected to DNA sequencing. The following primers 
were used as described elsewhere (13) F: 5'-CT-
CCCTGTTCTGTCCTAGCT- 3' R: 5'-CTCAT-
CCCTCTCATGCTGTC-3'. PCR condition was 
as follow: 2 µl MgCl2 (4 mM), 2.5 µl Taq PCR 
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buffer (10X), 1µl of each of the primers (10 PM), 
0.1 µl Taq DNA polymerase (5U/ul), 1 µl dNTP 
mix (10 mM) and 1µl DNA (about 70 ng). The 
reaction was adjusted to the volume of 25ul by 
ddH2O. Standard cycling conditions was performed 
in a thermocycler (ASTEC PC-818; ASTEC, Fu-
kuka, Japan) as follows: 95° C for 2 min; 35 cy-
cles of 94° C for 30'', 57° C for 45'', 72° C for 45'', 
and finally 72°C for 7 min. The PCR product of 
the GJB2 gene was quality controlled on the 1.5% 
agarose gel. A single PCR product of 809 bp was 
obtained.  
Subsequently, DNA sequencing of the PCR-am-
plified product was carried out bi-directionally on 
an ABI 3130 automated sequencer (Applied Bio-
systems) (Macrogen, South Korea) using the same 
primers. 
 
SLINK analysis and selection of DFNB loci  
Power of the pedigrees for linkage analysis was 
simulated by calculating SLINK, using FastSLink 
(version 2.51) option of Easylinkage plus version 
5.05 software to predict the potential LOD score 
in a given family (14). Families with SLINK scores 
above 2.5 were considered informative enough for 
linkage analysis by screening several known loci. 
The threshold SLINK value of 3.3 was consid-
ered significant for genome-wide scan (GWS). 
Based on the literature review of the most fre-
quent loci, both globally and regionally, 15 loci 
were selected for screening. Screening STR mark-
ers were selected based on their physical dis-
tance found at NCBI UniSTS and NCBI Map 
Viewer. STR markers of each locus and their primer 
sequences are listed in Table 1. 
 
Pooling strategy 
A subset of the samples was subjected to DNA 
pooling prior to genotyping by the following proto-
col: The concentration of DNA in the individual 
samples to be pooled was first estimated by meas-
uring UV light absorption at 260 nm. Samples 
were then diluted to 30 ng/ul and re-adjusted. The 
purity of samples was estimated by the absorption 
ratios of 260/280 and 260/230 nm. Equal amounts 
of each sample were pooled. Separate pools for 
normal and affected samples were prepared for 
each nuclear family of the pedigree. Af (1, 2,…) 
and N (1, 2,…..), representing different affected 
and normal pools, were used to label the pooled 
samples. In addition, critical samples with poor 
DNA qualities were analyzed individually. 
 
Genotyping STR markers and Linkage Analysis 
Fluorescent PCR of STR markers was conducted 
according to the standard procedure. Fragment 
analysis was carried out by capillary electropho-
resis with an ABI 3130 automated DNA sequencer 
(Applied Biosystems, California, USA). Alleles were 
assigned by Genescan software (Applied Biosys-
tems, Foster City, CA, USA). At least, two screen-
ing markers were analyzed for every known locus. 
Upon encountering an uninformative marker or find-
ing clues of linkage, further markers were genotyped.  
LOD score calculations were combined with haplo-
type analysis to confirm or exclude linkage. Two- 
point and multi-point parametric LOD scores were, 
respectively, calculated by Superlink version 1.6 
(15) and Simwalk version 2.91, both options of 
Easylinkage plus version 5.05 software (14). While 
two-point LOD score is much faster than multi-
point LOD score and provides an initial evalua-
tion of the linkage status, multi-point LOD score 
is more comprehensive and is able to provide 
haplotype data. AR mode of inheritance, complete 
penetrance, disease-allele frequency of 0.001, exis-
tence of no phenocopy, equal allele frequencies for 
markers and identical meiotic recombination fre-
quencies in both sexes were assumed for LOD 
score calculations. Haplotypes were reconstructed 
via Simwalk and were visualized by Haplopainter 
software version 029.5 (16).  
 
Results 
Families and clinical data 
The majority of subjects of this study displayed 
bilateral, severe to profound sensorineural prelin-
gual HL, whereas 3 families showed moderate to 
severe HL. Twenty-nine out of 37 families (78.4%) 
had at least one consanguinity loop within the pedi-
grees. Although the possibility of inbreeding was 
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not completely ruled out for the other families, 
particularly those living in isolated villages. 
 
Screening of GJB2  
DNA sequencing of the coding region of GJB2 
could reveal pathogenic variants in 6 out of 37 
studied families. The homozygous GJB2 mutations 
included 35delG (3 families), R127H (2 families) 
and 167delT (two families). These families were 
excluded from further analysis. As the coding region 
sequencing of GJB2 cannot completely rule out 
the DFNB1 as the disease-causing locus, the re-
maining families were further analyzed for the link-
age to DFNB1 using at least 3 informative mark-
ers. However, linkage analysis could not find any 
other family linked to DFNB1 locus.  
 
SLINK calculation  
Fifteen families were of SLINK values ≥3.3, Seven 
families had SLINK values of ≤2 .the rest of the 
families present value between 2-3.3. Later on, 
however, the lower families together with a subset 
of others were examined by DNA pooling strategy.  
DNA pooling, genotyping, and linkage analysis  
Screening loci for homozygosity mapping in this 
study were composed of: DFNB1 (GJB2), DFNB2 
(MYO7A), DFNB3 (MYO15A), DFNB4 (SLC26A4), 
DFNB6 (TMIE), DFNB7/11 (TMC1), DFNB8/10 
(TMPRSS3), DFNB9 (OTOF), DFNB12 (CDH23), 
DFNB21 (TECTA), DFNB22 (OTOA), DFNB28 
(TRIOBP), DFNB35 (ESRRB), DFNB59 (PJVK) 
and DFNB63 (LRTOMT). 
Ten out of the 31 families, all negative for DFNB1 
locus, were linked to six different loci, 4 of which 
had been found by performing the locus screen-
ing on the pools of the related families. The re-
sults were confirmed by individually genotyping the 
family members for the same markers, as well as 
additional markers. Table 2 shows the linked fami-
lies and the maximum values for SLINK, two-point 
and multi-point LOD scores. DFNB4 (4 families) 
was the most frequent locus, after DFNB1, in the 
studied ARNSHL series.  The haplotypes of the 
linked families are shown in Figure 1 (a-J). 
 
Table 1: The list of 15 DFNB loci screened in this study. The corresponding genes and details of screening markers are 
shown. Categories and functions of their encoded proteins are mentioned (52) 
 
Locus (gene), 
Physical location(bp), 
Category& function 
Marker 
Physical 
position 
(bp) 
PCR 
product 
range 
Forward primer (5'→3') Reverse primer  (5'→3') 
 
D13S1236 
 
22696180-
22696305 
 
108-132 
 
GCACTTGGCCTGGGTAA 
 
AAGGGGCTGGCTCTTCA 
D13S1275 - 180-214 ATCACTTGAATAAGAAGC CATTTG CCAGCATGACCTTTACCAG 
DFNB1(GJB2, GJB6) 
GJB2: 
20761602..20767114 
GJB6: 
20796101..20806534) 
Ion homeostasis 
proteins: 
 Connexins 
D13S175 20848506-20848618 101-113 
TATTGGATACTTGAATCT 
GCTG TGCATCACCTCACATAGGTTA 
D11S4179 76396260-76396495 200-256 
GGATGTAAGAGTAACTGG 
CTCCG GAAAATGTTCTGCCTGAGGG 
D11S4186 76968518-76968685 154-175 
ATTCTCCCAATCTATCG 
CTC GGGCAGTAATGATGATGTG 
D11S4079 77119447-77119701 217-265 
CAGCAAGATCCTGTCT 
CAA CTCCTTAAAGTGGGGGAGTT 
DFNB2 (MYO7A) 
76839310..76926286) 
Hair bundle 
morphogenesis proteins: 
Motor proteins 
 
  D11S911 77448583-77448769 159-203 
CTTCTCATGCTTGACC 
ATTT CTTCTGAACAATTGCCACAT 
D17S921 14260705-14260882 169-185 
CTTGGACTCCTACAA 
ATCCTGGCA 
GGCCACCATAATCATGTC 
AGACAAT 
D17S953 16102497-16102619 119-131 ACTATCCGCCCAATACA AAGGGCTTGCTTTGAC 
DFNB3 (MYO15A) 
18012020..18083116) 
Hair bundle 
morphogenesis proteins: 
Motor proteins 
  D17S2196 
17264482-
17264618 
 
139-163 
CCAACATCTAGAATT 
AATCAGAATC 
 
ATATTTCAATATTGTAACC 
AGTCCC 
 
Iranian J Publ Health, Vol. 40, No.2, 2011, pp.34-48 
38 
D7S2420 106889928-
106890211 240-290 
CCTGTATGGAGGGCAAA 
CTA 
AAATAATGACTGAGGCTCA 
AAACA 
D7S496 107154713-107154849 129-141 
AACAACAGTCAACCCAC 
AAT 
GCTATAACCTCATAANAA 
ACCAAAA 
D7S2459 107331501-107331642 140-152 
AAGAAGTGCATTGAGA 
CTCC CCGCCTTAGTAAAACCC 
D7S2456 107683218-107683460 238-252 
CTGGAAATTGACCTGAAA 
CCTT 
ACAGGGGTCTCTCACA 
CATATTA 
DFNB4 (SLC26A4) 
107301080..107358254) 
 Ion homeostasis 
proteins: 
 Ion channels 
  
  
D7S2425 108347079-108347322 234-246 
CTAGTCCTGAGAA 
GACATTACCC 
CCTGTTTCAGATGTT 
TTATCCA 
D3S3658 40903258-40903371 104-126 
AAAAGTTAGCAAA 
CACAATCCTATC 
CTGGACTAAATCTAAGT 
TGGTTATG 
DFNB6 (TMIE) 
46742823..46752413) 
Poorly understood 
function: integral 
membrane protein 
D3S2420 48067370-48067462 93-108 
ACAAGTGCGAAAC 
TCTGCCT 
CAGGAGCCTCTAAGT 
CAGCA 
D9S1837 75185129-75185367 205-251 
CATGATGGTGGTC 
TCTGG 
GGTGGGGCTCAAAG 
AGTAG 
D9S1806 74201357-74201620 216-266 
TTTTAGGTGTTCTCAGTA 
CATGC 
GGGAGCAACATTTT 
GACATT 
D9S1124 75224065-75224327 252-276 
GGTGCCCACCATACACT 
ACT 
TCTAATCCTTCCTT 
CCCTCG 
D9S1876 75232791-75232938 132-152 
GATGTACCCAGAGAAGT 
CTCG 
AGTGGTTACCATTTA 
CCCAAG 
D9S301 73802720-73802954 209-237 
AGTTTTCATAACACAAAA 
GAGAACA 
ACCTAAATGTTCATCA 
AAAGAGG 
D9S1822 74930323-74930483 157-163 
AAGTTTGGCTTCTGCTGT 
AAGGGTC 
AATTCCCCCAGGCT 
GAGTG 
DFNB7/11(TMC1 
75136717..75451267) 
 poorly understood 
function: integral 
membrane protein 
  
  
  
D9S1799 73366891-73367055 139-178 
TTGCCAACTATTTTAG 
CCC 
TGCAGTTTCAATCC 
ACATC 
D21S1890 44848178-44848330 143-173 
GGTCTGACCACAGAT 
TTCC 
AAAAACACTCTGAACG 
ATTAAGG 
DFNB8/10 (TMPRSS3) 
43791999..43816200) 
Poorly understood 
function: Serine 
protease 
D21S1260 42796042-42796251 200-214 TCCAAGGGGTTCATCC 
CCCAAGGCACT 
GTTCC 
D2S365 28606342-28606533 164-204 
ATGATTTGTGTACCTTA 
TGTATGTT 
TCAATGGAGGAAT 
CCTACTT 
D2S2247 27303911-27304064 130-160 TCCATCTTTTGCGTGC 
CCGTGCTCTATG 
CCAG 
D2S174 26839873-26840075 203-221 AGGCTGAATCCCACCTCC 
TTAGAGCACACATGG 
TCACTCC 
 DFNB9 (OTOF) 
26680071..26781566) 
 Poorly understood 
function: Exocytosis at 
auditory ribon synapse 
 
  D2S2223 26559144-26559325 182-200 CACTGCGCCTAGCCTC 
GGCGATTTATGAATA 
ATCCTGC 
D10S1432 74659396-74659569 157-185 
CAGTGGACACTAAACAC 
AATCC 
TAGATTATCTAAATGGT 
GGATTTCC 
DFNB12 (CDH23) 
73156704..73575704) 
 Hair bundle 
morphogenesis proteins: 
Adhesion proteins 
D10S1146 74659314-74659555 164-246 ATTGCACTCCAGCCTGGGT 
CACAATCCAATCACA 
TGGATG 
D11S4107 121049124-121049321 172-212 
TCATTCTACAAGACTAG 
CATTACC 
GCTTGATCATGGTGTA 
TTATCTT 
D11S925 120828264-120828438 172-199 
AGAACCAAGGTCGTAA 
GTCCTG 
TTAGACCATTATGG 
GGGCAA 
D11S912 128624097-128624205 101-123 
TCGTGAGANTACTGC 
TTTGG 
TTTTGTCTAGCCATG 
ATTGC 
D11S4151 126292160-126292309 145-155 
GTCTTCCCACCTTGGAT 
ATGGGTA 
AATGGGCACCTCCACCC 
TATTAGT 
D11S4089 120989673-120989875 199-213 
ATTCCTAGTTCCCTCAT 
AAACACTG 
TAATCAAAGGCTGTAGT 
GAATTGG 
DFNB21 (TECTA) 
120973375..121061515) 
Extracellular matrix 
proteins: Structural 
component tectorial 
membrane 
  
  
  
D11S4110 126971672-126971780 93-107 
TGAGCCTCCCAGTA 
CCTACC 
GTTTGTGGCAGAG 
CCCTAAG 
DFNB22 (OTOA) 
21689835..21772050) D16S3046 
20886507-
20886610 84-108 
CCCAGAATAAACTG 
CGTG 
TTCATGGACCCCC 
TATTG 
Table 1: Continued… 
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Extracellular matrix 
proteins: Anchoring protein 
between cellular gels and 
non-sensory cells 
D16S403 
 
23037651-
23037790 
 
134-152 
 
GTTTTCTCCCTGGGA 
CATTT 
 
TATTCATTTGTGT 
GGGCATG 
 
D22S1156 38381771-38381926 130-162 
TGAGGTAGTCACA 
CGAGGCA 
AATTCACTGGGCTCC 
GAGG 
 DFNB28 (TRIOBP) 
38092995..38172563) 
Hair bundle 
morphogenesis proteins: 
Proteins of the 
cytoskeleton 
D22S1045 37536298-37536453 140-158 
GCTAGATTTTCCCC 
GATGAT 
ATGTAAAGTGCTCTCAAG 
AGTGC 
D14S1015 92736133-92736396 224-264 
GAATGCCATTATTTT 
GTCCT 
TTAGAAAACACCGAG 
CAGA 
D14S77 73570540-73570772 203-251 GCGTGAGTCACTGTGCC 
CAGACAGAAATTAACC 
AGAGTTGAA 
D14S1045 0 240-246 AGGGCTGGTGACAATG GTAAGGNCTTGGGTGG 
DFNB35 (ESRRB) 
76837726..76967208) 
Transcription factors 
  
  D14S48 88428727-88429001 260-265 
CATAAAAGGCTTA 
TTGGTTTG 
CAAAACAGAGAACAG 
AGTAG 
D2S2981 176173334-176173578 234-262 
AAAATATGCAGGTA 
ATGACTTGG 
CAAGCAAAACTGACA 
GGTAGG 
D2S301 217887163-217887396 224-240 
CATAGGACTGAAG 
GGGTGTA 
GGAAAATCTCGAATG 
TACCAAT 
D2S2173 178445536-178445768 201-243 
GGAGACAGAGAGTT 
TACATTTGAG 
GCCACACTTTCCT 
GAATC 
D2S324 179656244-179656508 264-275 TTACCCACCGGGACAGT 
CAGCAAATGCTTCT 
AGGTCA 
D2S307 204654566-204654784 205-221 
CATGACCTGAAATA 
AACATAGACA 
AGCTTTTCCTGTAGG 
CTGTC 
DFNB59 (PJVK) 
179316163..179326113) 
Poorly understood 
function: Signaling of 
hair cells and neurons 
  
  
  
D2S2314 176862406-176862505 96-118 
GGTGTCAGTGA 
GACCCTGT 
ATTTCTAGCGGCCCT 
AAAAC 
D11S1314 72323192-72323414 209-227 
TTGCTACGCACTC 
CTCTACT 
GTGAAGGCAGGAAA 
TGTGAC 
D11S4132 119948397-119948596 176-214 
GTGCAAGTTTTGG 
CTTCGTC 
ACTCCAGCCTGGG 
TGAAA 
D11S4162 70975752-70976016 263-269 
GTTCTCCAGAGAG 
ACAGCAC 
GAGAGCAACACTA 
TTGCCC 
D11S4140 71945684-71945874 189-199 
TGCAACAAGGT 
TCCACACT 
CTTATGGGTGAGGG 
CACAG 
D11S4196 0 200-240 GAACGTTNTTCAT GTAGGCGT 
TAATGGTCGCTG 
TCCC 
DFNB63 (LRTOMT) 
71791382..71821828) 
leucine-rich 
methyltransferase 
  
  
  
  
D11S4184 72670843-72671103 263-277 
CCCAGCCTTA 
CATATTCC 
GCTGATGAGCAGA 
GGTAG 
Physical positions were determined from the National Center for Biotechnology Information (NCBI) Build 37.1 sequence-
based physical map (International Human Genome Sequence Consortium 2009). 
 
Table 2: Maximum SLINK and LOD score (two-point and multi-point) values for the linked families. Asterisk shows the 
family with Pendred syndrome 
 
Family ID Linked locus SLINK value Two-point LOD score Multi-point LOD score 
IR-JOL DFNB4 2.4 2.1 2.4 
IR-SH17* DFNB4 5.2 3.3 4.1 
IR-SH9 DFNB4 6.2 3.5 5.1 
IR-ABY DFNB4 7.4 3.4 4.6 
IR-GHA DFNB7/11 1.8 1.6 2.0 
IR-JAF DFNB21 2.9 2.6 3.1 
IR-SH5 DFNB9 3.9 3.2 3.3 
IR-SH6 DFNB2 4.4 3.6 4.2 
IR-HEM DFNB63 2.8 1.9 2.4 
IR-SH11 DFNB63 2.1 2.1 2.1 
 
Table 1: Continued… 
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Fig. 1: Pedigree of the 10 Iranian families with ARNSHL, negative for GJB2 mutations, linked to 6 known loci. Black 
symbols indicate affected individuals. For conciseness, some of the pedigrees are partly shown. haplotypes are shown below 
each symbol,  For individual families, the corresponding genetic map of the markers is shown in parenthesis. (a,b) linked to 
DFNB63: a) IR-HEM and b) IR-SH11 (LDB map), c) IR-SH5 linked to DFNB9 (LDB map), d) IR-GHA linked to DFNB7/ 
11(Marshfiled map), e) IR-SH6 linked to DFNB2 (LDB map), f) IR-JAF linked to DFNB21 (Marshfiled map), (g-J) linked 
to DFNB4: g) IR-SH9 (Marshfiled map), h) IR-SH17 (decode mapand  i) IR-ABY(LDB map) j) IR-JOL (Marshfiled map). In 
IR-ABY (i) a cross over must have happened in one of the upper generations of individual 1 between markers D7S2459 (which 
is an intragenic marker) and D7S2456, thus creating two haplotypes segregating with HL in two parts of the pedigree. 
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Discussion 
The locus DFNB1, harboring GJB2 and GJB6, 
was the first to be excluded in our study cohort 
composed of 37 families. It plays a major role in 
the pathology of ARNSHL worldwide. GJB2 mu-
tations have been estimated to account for up to 
50% of ARNSHL cases in the North American, 
Mediterranean, and most of the European popu-
lations (17-19). Thus, GJB2 was tested by both gene 
mutation screening and linkage analysis to strictly 
rule out the cause in the studied families. Further-
more, GJB6 deletions were investigated (13) with 
no finding of the mutations. DFNB1 linkage analy-
sis confirmed the results and showed no more 
positive family with DFNB1 involvement. Totally, 
16.2% of the families were homozygous for GJB2 
mutations which were set aside from further analy-
sis. This fits well with the 16.6% (20) or 18.3% (11) 
rate of GJB2 involvement in ARNSHL in previous 
studies on the Iranian population and would em-
phasize the diversity of the Iranian population and 
the fact that the contribution of other loci should 
be quested. Interestingly, two mutations 35delG 
(3 families) and R127H (2 families) that had been 
previously reported as the first and second preva-
lent mutations  in Iran (11), were found to cause 
HL in 5 of the 6 families with a mutation in GJB2 
in this study. Two families (IR-JAF and IR-Sh11), 
both heterozygous for the GJB2 mutation V37I, 
were included in homozygosity mapping for two 
reasons. At first, the pathogenicity of this variant 
has been doubted by some investigators (21). Sec-
ondly, there is a possibility to be carrier for this 
mutation but the real disease-causing gene would 
be different. However, both families showed link-
age to DFNB21 and DFNB63, respectively.  
Three out of 36 (8.3%) ARNSHL families of the 
study cohort were linked to DFNB4. One addi-
tional family, diagnosed as Pendred syndrome due 
to co-segregation of hypothyroidism (goiter) in later 
ages was also linked to the region containing 
SLC26A4, also known as PDS, which encodes 
pendrin, a chloride and iodide transporter (22). 
Its molecular pathology has been linked to both 
ARNSHL and Pendred syndrome. Although the 
prevalence of Pendred syndrome is not known ex-
actly, it seems to be the most common form of 
syndromic HL (23). Actually, distinction between 
Pendred syndrome and NSHL can be challeng-
ing since not all affected individuals may co-segre-
gate thyroid disease (24). 
About 5% of ARNSHL cases in South Asia have 
been tied to SLC26A4 mutations (25, 26). In a 
study, 12 families out of 80 (15%) Iranian families 
with 2 or more HL patients were linked to DFNB4 
locus with clues for 5 families to be syndromic (27). 
In a recent study, out of 34 families negative for 
GJB2, 3 families (8.8%) were linked to DFNB4. 
Thus, DFNB4 contributes significantly to HL in Iran 
and is ranked second after DFNB1. 
In our study, two families showed linkage to 
DFNB63. The locus which contains LRTOMT, has 
been reported in families of Turkish, Tunisian, and 
Pakistani origin (28, 29). In a study, a mutation in 
LRTOMT was identified in one out of 192 screened 
Iranian families (30). However, the true frequency 
of the locus might be more in the series since 
only catechol-O-methyltransferase (LRTOMT2) had 
been addressed and the possibility that mutations 
in isoforms of LRTOMT1 could lead to HL, can 
not be discounted. The finding of two DFNB63- 
linked families in our cohort may substantiate the 
above hypothesis. 
One out of 36 families (2.7%) was linked to DFNB2. 
The related gene MYO7A, encoding myosin VIIA, 
is a cytoskeletal motor proteins facilitating the 
movement of cell components along actin filaments 
(31). DFNB2- linked families have been reported 
from Iran (32, 33) and one family out of 40 
(2.5%) was found to be linked to DFNB2 (32).  
In our study, one family (2.7%) was linked to 
DFNB7/11. The novel gene, called TMC1, is re-
quired for postnatal hair cell development. TMC1 
mutations seem to be a rather common cause of 
ARNSHL in India and Pakistan (34). In a re-
search in the North East and East of Turkey, 
four out of 65 (6.2%) families, negative for GJB2, 
were shown to be linked to DFNB7/11 (35). The 
locus could be one a common causes of ARNSHL 
in the Iranian population. 
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One family (2.7%) was linked to DFNB9 (OTOF). 
In a study from Lebanon, 3 out of 30 families 
(10%) were linked to the locus (36). Other studies 
have reported DFNB9 from India (37) and UAE 
(38). OTOF mutations cause ARNSHL, which may 
be accompanied by auditory neuropathy in about 
half of cases, with important implications in DNA 
diagnostics (39).  
We found one family linked to DFNB21 in this 
study. The corresponding gene, TECTA, can cause 
both dominant and recessive HL TECTA encodes 
α-tectorin, a major non-collagenous constituent of 
the tectorial membrane that bridges the stereocilia 
bundles of the sensory hair cells (40). Interestingly, 
the DFNB21-linked family in our study, showed 
the distinctive audio profile (moderate to severe 
HL, more pronounced in the mid-frequencies) that 
has been suggested for DFNB21- linked families 
and is important in DNA diagnostics (41). In a 
study, linkage to DFNB21 was found in 3 (6.6%) 
out of 45 Iranian consanguineous families which 
were negative for GJB2 mutations (42). In another 
study on 75 Iranian families segregating ARNSHL, 
1 family (1.33%) was linked to DFNB21 (41) and 
finally, in a genetic linkage study of forty ARNSHL  
families living in Markazi and Qom provinces of 
Iran with at least 3 affected individuals per family, 
no instance of linkage to DFNB21 was found (32).  
No linkage was found to DFNB3 in any of the study 
families. The corresponding gene, MYO15, codes for 
myosin XV that is necessary for actin organization 
in hair cells (43). It has been suggested that at least 
5% of the studied Pakistani population are caused by 
the gene (44). Unlike our study, with no DFNB3-
linked family, in a recent study on 40 Iranian AR-
NSHL families from Qom and Markazi provinces of 
Iran with 3 or more patients, 2 families were linked 
to DFNB3 (5.8%) (32). Thus, the prevalence of the 
DFNB3 HL may vary among Iranian populations. 
More ARNSHL families have to be studied before 
reaching any definite conclusion in this regard. 
No family was linked to DFNB59. The locus has 
been mapped to 2q31.2, and the corresponding 
gene, PJVK encoding pejvakin, has been identi-
fied in 4 Iranian families (45). Pejvakin plays a role 
in action potential propagation or intracellular traf-
ficking. Like OTOF, its defects can sometimes cause 
auditory neuropathy (45). Thus, in case of audi-
tory neuropathy, both DFNB9 and DFNB59 are 
strong candidates from the DNA diagnostic stand-
point. Screening of 67 Turkish ARNSHL families 
led to finding of a linked family. It was concluded 
that it was not playing a significant role in the patho-
genesis of HL in the Turkish patients (46). In a 
study on 30 Iranian ARNSHL families, 2 families 
(6.7%) were found to be linked. The investigators 
proposed checking the locus in the Iranian ARNSHL 
families (47). Based on our study, It is possible 
that DFNB59 plays no major role in the patho-
genesis of ARNSHL. 
As a sub-goal of the study, we successfully per-
formed the DNA pooling strategy for a subset of 
the families. In the DNA pooling, the DNA sam-
ples are segregated into pools based on the con-
trast phenotype. Thus, in an inbred family linked 
to a given locus, it is expected that affected indi-
viduals would be homozygous for a single marker 
allele closely linked to the given locus and is thus 
“hunted” (48).While the attraction of pooling lies in 
reducing time and expense for genotyping indivi-
duals, some information, that could have been ob-
tained by individual genotyping, might be lost (49). 
This can specially occur if more than one cause 
of hearing loss is segregating in a family. Other 
pitfalls include differential amplification of alleles 
and the STR stutter bands, the PCR artifacts associ-
ated with STR markers that can sometimes com-
plicate allele calling of individual pools (50). As 
to tackle with some of its limitations, for the pe-
digrees showing possible clues of digenic inheri-
tance, based on the structure of the pedigrees or 
audiometric profiles, a number of screening mark-
ers were independently checked on the individu-
als. In this experiment, we applied a set of ad-
justments to successfully conduct the DNA pooling 
and could find 4 linked families which were con-
firmed by further genotyping in the corresponding 
family individuals. Our result shows that the strat-
egy could easily be applied to the studies of ge-
netic linkage covering the extraordinary big pedi-
grees or those with SLINK values lower than 2.5, 
which are often discarded from additional analyses. 
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In the present study, we could only clarify the 
genetic etiology of 16 out of 37 (43.2%) HL fa-
milies, including 36 ARNSHL families and one 
with Pendred syndrome, and 15 out of 36 (41.6%) 
ARNSHL families. This could be explained by the 
extreme heterogeneity of the disease arising from 
the complexity of the auditory system, and the lower 
contribution of DFNB1 (GJB2) in Iran as com-
pared to some other populations. The results of 
the present study confirm those of previous studies 
in Iran. The results would also give an overview of 
the most frequent loci: DFNB1, DFNB4, DFNB2, 
DFNB21 and DFNB7/11. It might be worthwhile 
including also DFNB63 in the locus-screening list 
of future studies on Iranian ARNSHL patients. 
The design and practice of similar studies on the 
different populations of Iran will provide a wealth 
of population-specific knowledge for genetic diag-
nosis and genetic counseling of the families. 
The next phase of the study involves the DNA 
sequencing of the known DFNB genes we have 
already mapped in the linked families as to iden-
tify their underlying pathogenic mutations in the 
families. Several families with SLINK≥ 3.3 are 
currently being subjected to GWS by the llumina 
SNP array utilizing 6K SNP Linkage Panel IVb 
(Illumina Inc., San Diego, CA). Thus far, one novel 
locus (DFNB93) for hearing loss has been iden-
tified (51). 
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